drugset / Trial / NCT01251627
Multicenter Study to Assess the Efficacy of Decitabine in the Treatment of Chronic Myelomonocytic Leukemia
Phase 2
Completed
43 enrolled
Fondazione Italiana Sindromi Mielodisplastiche-ETS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte · collab
NaSingle-groupOpen-labelTreatment
Summary
The study aims to assess the activity of decitabine in the treatment of CMML.
Timeline
- Start
- 2010-04
- Primary completion
- 2011-12
- Completion
- 2018-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Decitabine | Small molecule | 20 mg/m2 | Intravenous |